Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade

分组1 - Avita Medical Inc. (RCEL) shares have increased by 17.9% over the past four weeks, closing at $5.39, with a mean price target of $7 indicating a potential upside of 29.9% [1] - The mean estimate consists of four short-term price targets with a standard deviation of $3.03, where the lowest estimate is $3.50 (a 35.1% decline) and the highest is $10.00 (an 85.5% increase) [2] - Analysts show strong agreement on RCEL's ability to report better earnings than previously predicted, which supports the view of potential upside [4] 分组2 - The Zacks Consensus Estimate for RCEL's current year earnings has increased by 12.2% over the last 30 days, with one estimate moving higher and no negative revisions [12] - RCEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, the implied direction of price movement appears to be a useful guide [14]